BiotechTube
Home/Envisagenics/Martin Akerman, PhD
MA

Martin Akerman, PhD

CEO & Co-founder, Board Member

Envisagenics

Therapeutic Areas

OncologyNeurodegenerative Diseases

Envisagenics Pipeline

DrugIndicationPhase
SpliceCore® Discovery PipelineOncology (Immuno-oncology) & Neurodegenerative DiseasesPre-clinical

Leadership Team at Envisagenics

MP
Maria Pineda, PhD
CEO & Co-founder, Board Member
BH
Bradley Harris, JD
COO & General Counsel
SR
Sudhir Rao, MS MBA
CBO
GA
Gayatri Arun, PhD
EVP of Biology
View full Envisagenics profile